AbCellera Biologics Inc

NASDAQ:ABCL   10:21:26 AM EDT
16.15
-0.32 (-1.94%)
Earnings Announcements

Abcellera Reports Full Year 2020 Business Results

Published: 03/29/2021 20:20 GMT
AbCellera Biologics Inc (ABCL) - Abcellera Reports Full Year 2020 Business Results.
Revenue is expected to be $16.2 Million
Adjusted EPS is expected to be -$0.03

Next Quarter Revenue Guidance is expected to be $18.48 Million
Next Quarter EPS Guidance is expected to be -$0.03

More details on our Analysts Page.